Research Topics
| Thierry VialSummaryAffiliation: Hospices Civils de Lyon Country: France Publications
| Collaborators
|
Detail Information
Publications
Endocrine and neurological adverse effects of the therapeutic interferonsT Vial
Lyon Poison Centre and Pharmacovigilance Unit, Hopital Edouard Herriot, France
Toxicology 142:161-72. 2000....- Autoimmune diseases and vaccinationsThierry Vial
Centre Antipoison et Centre Régional de Pharmacovigilance, 162, avenue Lacassagne, 69424 Lyon, France
Eur J Dermatol 14:86-90. 2004..We suggest that a potential link between vaccines and autoimmune diseases cannot be definitely ruled out and should be carefully explored during the development of new candidate vaccines... - Sideroblastic anaemia during fusidic acid treatmentT Vial
Centre Antipoison Centre de Pharmacovigilance de Lyon, 162 Avenue Lacassagne, 69424 Lyon, France
Eur J Haematol 72:358-60. 2004..To describe cases of fusidic acid-associated sideroblastic anaemia from the French Pharmacovigilance database... - Immunosuppressive drugs and cancerThierry Vial
Lyon Poison Centre and Pharmacovigilance Unit, Unit 5 Place d Arsonval, Hopital Edouard Herriot, 69437 Lyon Cedex 03, France
Toxicology 185:229-40. 2003..The increasing use of immunosuppressive drugs in nontransplant patients is useful to delineate more accurately the consequences of mild-to-moderate immunosuppression... - Adverse effects of immunotherapeutics involving the immune systemT Vial
Poison Center and Pharmacovigilance Unit, Hopital E Herriot, 5 Place d Arsonval, 69437 Cedex 03, Lyon, France
Toxicology 174:3-11. 2002..These untoward and potentially severe consequences support the need for a careful preclinical and clinical evaluation of the immunotoxicity of these products... - Low-molecular-weight heparins and thrombocytosisChristine Liautard
Centre Antipoison, Centre de Pharmacovigilance, Hopital Edouard Herriot, Lyon, France
Ann Pharmacother 36:1351-4. 2002..This association is not mentioned in LMWH's summary of product characteristics... - Precocious puberty and unlicensed paediatric drugs for severe hyperparathyroidismJustine Bacchetta
Service de Néphrologie et Rhumatologie Pédiatriques, Centre de Référence des Maladies Rénales Rares, Hopital Femme Mere Enfant, Bron, France
Nephrol Dial Transplant 24:2595-8. 2009..Monitoring of plasma testosterone in patients receiving unlicensed paediatric drugs for managing hyperparathyroidism and presenting with a change in genitals is therefore recommended... - Pheochromocytoma unmasked by amisulpride and tiaprideAgnes Henry
Pharmacy Department, Croix Rousse Hospital, Lyon, France
Ann Pharmacother 39:970-2. 2005..To describe the unmasking of pheochromocytoma in a patient treated with amisulpride and tiapride... - 'Renal hypersensitivity' to inulin and IgA nephropathyJustine Bacchetta
Centre de Référence des Maladies Rénales Rares, Hospices Civils de Lyon et Université Lyon 1, Lyon, France
Pediatr Nephrol 23:1883-5. 2008..We can hypothesize that inulin had activated the innate immune system. Inulin may, thus, have been the initiating event of the renal relapse, acting like an infection, in a patient with IgA-mediated immunological dysregulation... - Piribedil-induced sleep attacks in patients without Parkinson disease: a case seriesAurore Gouraud
Poison Center and Pharmacovigilance Department, Lyon University Hospitals, Lyon, France
Clin Neuropharmacol 34:104-7. 2011..After a spontaneous report of sleep attack associated with piribedil use in a non-PD patient, we reviewed other cases from the French pharmacovigilance database... - Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazoleAurore Gouraud
Poison Centre and Pharmacovigilance Department, University Hospitals, Lyon, France
Clin Drug Investig 30:559-63. 2010..In these patients, close haematological monitoring is proposed... - Atenolol hepatotoxicity: report of a complicated caseJerome Dumortier
Department of Digestive Diseases, Edouard Herriot Hospital, Lyon, France
Ann Pharmacother 43:1719-23. 2009..To report a case of acute hepatitis related to atenolol administration in a liver transplant (LT) recipient... - [Preclinical evaluation of the safety of biotechnology products: specific aspects]Jacques Descotes
Centre Antipoison, Centre de Pharmacovigilance, Hopital Edouard Herriot, Lyon, France
Therapie 58:139-43. 2003..Overall, biotechnology-derived products raise specific issues because of their innovative and original characteristics, and it is difficult to address all these issues if not by using a case-by-case approach... - Paclitaxel hypersensitivity reactions: assessment of the utility of a test-dose programAgnes Henry
Pharmacy Department, Croix Rousse Hospital, Lyon, France
Cancer J 12:237-45. 2006..The aim of this study was to assess the utility of implementing such a test dose... - Allergic adverse reactions to sulfonamidesGenevieve Choquet-Kastylevsky
bioMerieux, Chemin de l orme, 69280 Marcy l Etoile, France
Curr Allergy Asthma Rep 2:16-25. 2002..Diagnosis is essential to avoid a possible evolution toward severe reactions and readministration of the offending drug. In patients who absolutely require further treatment, successful desensitization may be achieved... - [Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale]Pascale Olivier
Service de Pharmacologie Clinique, centre Midi Pyrénées de pharmacovigilance, de Pharmacoépidémiologie et d Informations sur le Medicament Inserm U657, Faculte de Medecine, Toulouse, France
Therapie 60:39-45. 2005..This experience suggests the need for further studies to improve this French ADR preventability scale and validate it in differing circumstances, in order to provide a useful tool to enhance the rational use of drugs... - Hypersensitivity to inulin: a rare and mostly benign eventJustine Bacchetta
Am J Kidney Dis 52:632-3. 2008 - The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational studyCorinna Weber-Schoendorfer
Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie, BBGes, Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, 14050 Berlin, Germany
Reprod Toxicol 26:24-30. 2008..To assess the safety of calcium channel blockers during the first trimester of pregnancy... - Non-interventional research and usual care: definition, regulatory aspects, difficulties and recommendationsFrancois Lemaire
Medical Intensive Care, Henri Mondor Hospital, Creteil, France
Therapie 63:103-6, 97-101. 2008.... - Hidden cardiac lesions and psychotropic drugs as a possible cause of sudden death in psychiatric patients: a report of 14 cases and review of the literatureDominique Frassati
Centre Hospitalier Le Vinatier, Bron, France
Can J Psychiatry 49:100-5. 2004..Patients should be systematically evaluated for cardiac lesions prior to starting any treatment with psychotropic drugs; the minimal effective dosage should be used... - [Liver toxicity associated with oral anticoagulant treatment: report of two cases]Thomas Walter
Gastroenterol Clin Biol 31:615-6. 2007 - [Contact dermatitis caused by acetazolamide under occlusion]Amélie Daveluy
Centre de Pharmacovigilance, Departement de Pharmacologie, INSERM U657, Universite Victor Segalen, CHU, Bordeaux
Presse Med 36:1756-8. 2007..Acetazolamide is a carbonic anhydrase inhibitor used topically for local secondary treatment of posttraumatic or postoperative edema... - Tacrolimus severe overdosage after intake of masked grapefruit in orange marmaladeDelphine Peynaud
Eur J Clin Pharmacol 63:721-2. 2007 - Vitamin K antagonists and pregnancy outcome. A multi-centre prospective studyChristof Schaefer
Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie, Berliner Betrieb für Zentrale Gesundheitliche Aufgaben, Spandauer Damm 130, Haus 10, 14050 Berlin, Germany
Thromb Haemost 95:949-57. 2006..Close follow-up by the obstetrician including level II ultrasound should be recommended in any case of VKA exposure during pregnancy...